Clinical Trial on Acupuncture Adjuvant Treatment in the Pain After the Surgery of Gastrointestinal Carcinoma

January 24, 2019 updated by: Xiaonan Cui
Clinical trial on acupuncture adjuvant treatment in the pain after the surgery of gastrointestinal carcinoma. Gastrointestinal cancer patients are diagnosed by pathology or cell biology. Patients are randomized into 2 groups: The control group receive normal treatment only, the experimental group receive acupuncture therapy besides normal treatment. Clinical evaluation is based on the observation of the pain degree and life quality improvement. Blood biochemistry tests mainly include Prostaglandin E2(PGE2),5-hydroxytryptamine(5-HT), histamine(HIS), malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), adrenaline, nor-adrenaline, tumor necrosis factor (TNF)-α, cell flow cytometry on Th1, Th2, Th17, Treg cytokines as well as serum cortisol, estradiol (female), progesterone (female), testosterone (male) etc.

Study Overview

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. General anesthesia,Gastric and Colorectal Cancer surgery under Laparoscopic;
  2. Pathology diagnosed;
  3. Brain, heart, lung, liver, kidney are at good condition before surgery;
  4. No mental disorder, no conscious obstacle, no limbs disability.

Exclusion Criteria:

  1. Severely complication after surgery;
  2. Contraindication of the acupuncture;
  3. Patients with mental disease;
  4. Patients taking part in other clinical trials, being treated with other biotherapy or immunotherapy and researchers consider not suitable for clinical subjects for other reasons will be excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control group
This group receives normal treatment after surgery,with no acupuncture.
Experimental: Experimental group
This group receives acupuncture therapy besides normal treatment after surgery. The acupuncture therapy starts after 24 hours of surgery, 1 time a day, 30 minutes every time, until the fifth day.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Pain degree change after surgery, Graded according to Numerical Rating Scale(NRS)
Time Frame: day 1, day 2, day 3, day 4, day 5, day 6, day 7 after surgery
day 1, day 2, day 3, day 4, day 5, day 6, day 7 after surgery

Secondary Outcome Measures

Outcome Measure
Time Frame
Assessing the quality of life(QOL) change in 4 grades and recording: appetite, mental state, sleep, fatigue, attitude towards treatment, daily life ability
Time Frame: day 1, day 2, day 3, day 4, day 5, day 6, day 7 after surgery
day 1, day 2, day 3, day 4, day 5, day 6, day 7 after surgery
Prostaglandin E2(PGE2) in blood
Time Frame: day 2,day 7 after surgery
day 2,day 7 after surgery
Estradiol(Female) in blood
Time Frame: day 2, day 7 after surgery
day 2, day 7 after surgery
Th1/Th2 in blood
Time Frame: day 2, day 7 after surgery
day 2, day 7 after surgery
5-Hydroxytryptamine(5-HT) in blood
Time Frame: day 2,day 7 after surgery
day 2,day 7 after surgery
Histamine(HIS) in blood
Time Frame: day 2,day 7 after surgery
day 2,day 7 after surgery
Th17/Treg in blood
Time Frame: day 2, day 7 after surgery
day 2, day 7 after surgery
Testosterone(Male) in blood
Time Frame: day 2,day 7 after surgery
day 2,day 7 after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2016

Primary Completion (Actual)

January 1, 2019

Study Completion (Actual)

January 1, 2019

Study Registration Dates

First Submitted

August 3, 2016

First Submitted That Met QC Criteria

August 15, 2016

First Posted (Estimate)

August 18, 2016

Study Record Updates

Last Update Posted (Actual)

January 25, 2019

Last Update Submitted That Met QC Criteria

January 24, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Laparoscopic Surgery

3
Subscribe